These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1577071)

  • 1. Specificity of antigen processing for MHC class I restricted presentation is conserved between mouse and man.
    Falk K; Rötzschke O; Rammensee HG
    Eur J Immunol; 1992 May; 22(5):1323-6. PubMed ID: 1577071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
    Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
    Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes.
    Buckner FS; Wipke BT; Van Voorhis WC
    Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both human and mouse cells expressing H-2Kb and ovalbumin process the same peptide, SIINFEKL.
    Falk K; Rötzschke O; Faath S; Goth S; Graef I; Shastri N; Rammensee HG
    Cell Immunol; 1993 Sep; 150(2):447-52. PubMed ID: 8370082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
    Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
    Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
    Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
    Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene transfer experiments imply instructive role of major histocompatibility complex class I molecules in cellular peptide processing.
    Wallny HJ; Rötzschke O; Falk K; Hämmerling G; Rammensee HG
    Eur J Immunol; 1992 Mar; 22(3):655-9. PubMed ID: 1372256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity and frequency of primary anti-HLA cytotoxic T lymphocytes in normal and HLA-B27.2-, HLA-B27.5-, and HLA-Cw3-transgenic mice. A transgenic model for MHC xenoantigen recognition.
    Kievits F; Boerenkamp WJ; Lokhorst W; Ivanyi P
    J Immunol; 1990 Jun; 144(12):4513-9. PubMed ID: 2351823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes.
    Heath WR; Hurd ME; Carbone FR; Sherman LA
    Nature; 1989 Oct; 341(6244):749-52. PubMed ID: 2477713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells.
    Rötzschke O; Falk K; Deres K; Schild H; Norda M; Metzger J; Jung G; Rammensee HG
    Nature; 1990 Nov; 348(6298):252-4. PubMed ID: 1700304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of epitopes recognized by alloreactive cytotoxic T lymphocytes using inhibition by MHC peptides.
    Heath WR; Vitiello A; Sherman LA
    J Immunol; 1989 Sep; 143(5):1441-6. PubMed ID: 2474598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides.
    Wang W; Man S; Gulden PH; Hunt DF; Engelhard VH
    J Immunol; 1998 Feb; 160(3):1091-7. PubMed ID: 9570521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells.
    Aosai F; Ohlen C; Ljunggren HG; Höglund P; Franksson L; Ploegh H; Townsend A; Kärre K; Stauss HJ
    Eur J Immunol; 1991 Nov; 21(11):2767-74. PubMed ID: 1936122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M; Pendleton CD; Berzofsky JA
    J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endogenous peptides in murine allogenic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM.T2.
    Crumpacker DB; Alexander J; Cresswell P; Engelhard VH
    J Immunol; 1992 May; 148(10):3004-11. PubMed ID: 1374446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular peptide composition governed by major histocompatibility complex class I molecules.
    Falk K; Rötzschke O; Rammensee HG
    Nature; 1990 Nov; 348(6298):248-51. PubMed ID: 2234092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloreactive cytotoxic T cells recognize MHC class I antigen without peptide specificity.
    Müllbacher A; Hill AB; Blanden RV; Cowden WB; King NJ; Hla RT
    J Immunol; 1991 Sep; 147(6):1765-72. PubMed ID: 1890303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
    Zügel U; Schoel B; Kaufmann SH
    J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential binding of a minor histocompatibility antigen peptide to H-2 class I molecules correlates with immune responsiveness.
    Wettstein PJ; van Bleek GM; Nathenson SG
    J Immunol; 1993 Apr; 150(7):2753-60. PubMed ID: 7681080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T lymphocyte response to minor H-43a alloantigen in H-43b mice. Privileged H-2Kb restriction to the response is not due to immunodominance or epistatic effect but due to Ir gene function of H-2Kb itself.
    Hino T; Ishikawa H; Saito K
    J Immunol; 1988 Jan; 140(1):44-51. PubMed ID: 3121741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.